|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
��������������� |
|
����ѧ |
| ��������������� | |
|
�Ծ��� |
|
���� |
| PubMed | |
|
Article by |
|
Article by |
���������������������ѧ�����о���չ
�Ծ���, ��ά��
�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧƤ�����о���, �Ͼ� 210042
�����������������һ�ֳ���������ճĤ�������Ⱦ�Լ���,�Ը�Ů�������нϴ���˺�,�������Դ˲��ķ�����������������ѧ�������ٴ���ʵ�鶯�﷽����о�����,�����ķ���������Ҫ�������ֲ�������ѧ�����й�,��ʾ����ѧ���ƽ���Ϊ����������һ������ǰ�����ֶ�.
[2] Fidel PL Jr,Lynch ME,Sobel JD.Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis.Infect Immun,1994,62(3):1032-1038.
[3] Fidel PL Jr,Lynch ME,Sobel JD.Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis.Infect Immun,1995,63(7);2403-2408.
[4] Cantoma M,Mook D,Balish E.Resistance of congenitally immunodeficient gnotobiotic mice to vaginal candidiasis.Infect Immun,1990,58(11);3813-3815.
[5] Fidel PL Jr,Lynch ME,Conaway DH,et al.Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity.Infect Immun,1995,63(2);547-553.
[6] Taylor BN,Saavedra M,Fidel PL Jr.Local Thl/Th2 cytokine production during experimental vaginal candidiasis:potential importance of transforming growth factor-beta.Med Mycol,2000,38(6):419-431.
[7] Saavedra M,Taylor B,Lukacs N,et al.Local production of chemokines during experimental vaginal candidiasis.Infect Immun,1999,67(11):5820-5826.
[8] Wormley FL Jr,Chalban J,Fidel PL Jr.Cell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasis.Infect Immun,2001,69(8):5072-5079.
[9] Polonelli L,De Bernardis F,Conti S,et al.Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory,yeast killer toxin-like anti-idiotypic antibodies.J Immunol,1994,152(6):3175-3182.
[10] de Bernardis F,Santoni G,Boccanera M,et al.Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans.Infect Immun,2000,68(6);3297-3304.
[11] Fong IW,McCleary P,Read S.Cellular immunity of patients with recurrent or refractory vulvovaginal moniliasis.Am J Obstet Gynecol,1992,166(3);887-890.
[12] Nawrot U,Grzybek-Hryncewicz K,Zielska U,et al.The study of cellmediated immune response in recurrent vulvovaginal candidiasis.FEMS Immunol Med Microbiol,2000,29(2):89-94.
[13] Fidel PL Jr,Lynch ME,Sobel JD.Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis.Infect Immun,1993,61(10);4202-4207.
[14] Fidel PL Jr,Lynch ME,Redondo-Lopez V,et al.Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis.J Infect Dis,1993,168(6);1458-1465.
[15] Weissenbacher S,Witkin SS,Tolbert V,et al.Value of Candida polymerase chain reaction and vaginal cytokine analysis for the differential diagnosis of women with recurrent vulvovaginitis.Infect Dis Obstet Gynecol,2000,8(5-6);244-247.
[16] Mathur S,Koistinen GV,Horger EO 3rd,et al.Humoral immunity in vaginal candidiasis.Infect Immun,1977,15(1);287-294.
[17] Rigg D,Miller MM,Metzger WJ.Recurrent allergic vulvovaginitis:treatment with Candida albicans allergen immunotherapy.Am J Obstet Gynecol,1990,162(2):332-336.
[18] Moraes PS,de Lima Goiaba S,Taketomi EA.Candida albicans allergen immunotherapy in recurrent vaginal candidiasis.J Investig Allergol Clin Immunol,2000,10(5);305-309.